Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities
Net income	$ 1,138	$ 1,363
Adjustments to reconcile net income to net cash Provided by (used in) operating activities:
Depreciation	584	718
Net amortization of security premiums/discounts	1,163	907
Net amortization of mortgage servicing rights	619	609
Impairment of foreclosed real estate	745	988
Impairment of recovery of other assets	(75)	50
Provision for (recovery of) loan losses	(547)	1,094
Stock compensation		3
Net realized gain on sales / calls available for sales securities	(14)	(16)
Income from mortgage loan sales	(1,843)	(2,578)
Proceeds from sales of loans held for sale	67,218	89,969
Origination of loans held for sale	(60,562)	(86,458)
Gain on sale of premises, equipment and other assets	(229)	(276)
Increase in cash surrender value of life insurance	(92)	(183)
(Gain) loss on sales of foreclosed real estate	(18)	60
Release of ESOP shares	34	35
Net change in interest receivable	135	149
Net change in other assets	(576)	137
Net change in interest payable	(39)	(24)
Net change in other liabilities	3,454	873
Net cash provided by operating activities	11,095	7,420
Cash flows from investing activities
Proceeds from sales, maturities and calls of securities available for sale	11,413	19,215
Purchase of securities available for sale	(46,693)	(61,369)
Net decrease in loans	12,768	24,845
Proceeds from sales of premises, equipment and other assets	949
Purchase of premises and equipment	(237)	(610)
Proceeds from sales of foreclosed real estate	1,994	1,724
Investment in other assets	(356)	(260)
Net decrease in restricted stock	946	1,024
Net cash used in investing activities	(19,216)	(15,431)
Cash flows from financing activities
Net increase in deposit accounts	5,372	19,062
Net decrease in short-term borrowed funds	(12,686)	(156)
Net decrease in long-term debt	(1,508)	(12,557)
Proceeds from preferred stock series B issued by subsidiaries	360
Repayment of preferred stock series A	(7,742)
Increase in unearned ESOP compensation	(69)	(176)
Repurchase of common stock	(92)	(243)
Dividend and discount accretion on preferred stock	(215)	(409)
Dividend and cost accretion on noncontrolling interest	(311)
Net cash provided (used in) in financing activities	(16,891)	5,521
Increase (decrease) in cash and cash equivalents	(25,012)	(2,490)
Cash and cash equivalents, beginning of period	81,728	28,687
Cash and cash equivalents, end of period	56,716	26,197
Supplemental Disclosures of Cash Flow Information
Interest paid	2,170	2,846
Income taxes paid	648	78
Supplemental Schedule of Non-Cash Activities
Net change in fair value securities available for sale, net of tax	(1,721)	230
Loans transferred to foreclosed real estate	3,272	1,649
Company financed sales of other real estate owned	(213)	(188)
Net change in ESOP liability	$ 63